XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.2
Note 15 - Share-based Compensation (Tables)
9 Months Ended
Jun. 30, 2023
Notes Tables  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   

Nine months ended

 
   

June 30,

 
   

2023

   

2022

 

Volatility

    52.1 %     48.1 %

Risk-free interest rate

    4.0 %     1.5 %

Dividend yield

    0.0 %     0.0 %

Expected term in years

    5.8       6.8  
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

 

 

Number of Shares

   

Weighted

Average Grant

Date Fair Value

 

Outstanding September 30, 2022

    342,841     $ 4.11  

Granted

    295,600     $ 3.63  

Released

    (253,012 )   $ 3.73  

Forfeited/cancelled

    -     $ -  

Outstanding June 30, 2023

    385,429     $ 3.99  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
   

Number of Shares

   

Weighted

Average

Exercise Price

 

Outstanding September 30, 2022

    3,940,899     $ 3.31  

Granted

    1,849,500     $ 2.93  
Forfeited/expired     (1,480,362 )   $ 3.98  

Exercised

    (1,022,265 )   $ 1.96  

Outstanding June 30, 2023

    3,287,772     $ 3.21  

Exerciseable June 30, 2023

    817,726     $ 3.41  
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

Range of

 

Number

   

Weighted

Average

Remaining Contractual

   

Weighted

Average

Exercise

   

Number

   

Weighted

Average

Exercise

 

Exercise Prices

 

Outstanding

   

Term

   

Price

   

Exercisable

   

Price

 

$1.51

- $2.64     189,157       1.88     $ 1.88       159,157     $ 1.73  

$2.69

- $2.69     1,100,000       6.27     $ 2.69       -     $ -  

$3.09

- $3.39     1,160,388       4.93     $ 3.33       192,138     $ 3.39  

$3.40

- $8.03     838,227       4.76     $ 4.04       466,431     $ 3.99  
          3,287,772       5.16     $ 3.21       817,726     $ 3.41  
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
   

Three Months Ended

   

Nine Months Ended

 
   

June 30,

   

June 30,

 
   

2023

   

2022

   

2023

   

2022

 

Cost of revenues

  $ 19     $ 10     $ 80     $ 53  

Selling, general and administrative

    351       327       1,171       1,544  

Research and development

    26       18       78       53  
    $ 396     $ 355     $ 1,329     $ 1,650